The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6810135 7357509 F 6810135-1 20100331 20100617 20100630 EXP CH-GENZYME-POMP-1000908 GENZYMEP 27 YR F Y 42 KG 20100630 MD SWITZERLAND

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6810135 1014006329 PS MYOZYME 1 INTRAVENOUS 20 MG/KG, Q2W
6810135 1014006330 C PANTOZOL 2 20 MG, UNK
6810135 1014006331 C CLEMASTINE FUMARATE 1 1 MG, UNK

Indications of drugs used

Event ID DRUG SEQ INDI PT
6810135 1014006329 GLYCOGEN STORAGE DISEASE TYPE II
6810135 1014006330 PREMEDICATION
6810135 1014006331 PREMEDICATION

Outcome of event

Event ID OUTC COD
6810135 HO
6810135 OT

Reactions reported

Event ID PT
6810135 CHILLS
6810135 DYSPEPSIA
6810135 GLOMERULONEPHRITIS MEMBRANOUS
6810135 NEPHROTIC SYNDROME
6810135 RASH

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6810135 1014006329 20070612